LexDanaLexDanabeta
Inventor

RENE DE WAAL MALEFYT

Inventor
US

Overview

3→
Patents
2021–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07KPeptides20%
G01NInvestigating or analysing materials by determining their chemical or physical properties20%
Y02ATechnologies for adaptation to climate change20%
PatentTitleYear
12,102,681Anti-LAG3 antibodies and antigen-binding fragments202411,278,620Anti-LAG3 antibodies and antigen-binding fragments202211,207,406Anti-LAG3 antibodies and antigen-binding fragments2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2022Patents assigned to MERCK SHARP & DOHME (2)· patent assignee history
2021–2024Based in US· patent location history
2024Patents assigned to MERCK SHARP & DOHME LLC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MERCK SHARP & DOHME22021–2022
MERCK SHARP & DOHME LLC12024
Locations
LocationPatentsSpan
US32021–2024